Relationship between the Proportion of Tumor Infiltrating Lymphocytes in Tumor Mass and Postoperative Recurrence of Prostate Carcinoma

Ran Zhen; Zhu Yun Sha; Hai Bing; Zhang Jing Song

Article Contents

Article Navigation > Journal of Kunming Medical University > 2018 > 39(03): 62-66

Ran Zhen , Zhu Yun Sha , Hai Bing , Zhang Jing Song . Relationship between the Proportion of Tumor Infiltrating Lymphocytes in Tumor Mass and Postoperative Recurrence of Prostate Carcinoma[J]. Journal of Kunming Medical University, 2018, 39(03): 62-66.

Citation:

Ran Zhen , Zhu Yun Sha , Hai Bing , Zhang Jing Song . Relationship between the Proportion of Tumor Infiltrating Lymphocytes in Tumor Mass and Postoperative Recurrence of Prostate Carcinoma[J]. Journal of Kunming Medical University, 2018, 39(03): 62-66.

Citation:

Ran Zhen , Zhu Yun Sha , Hai Bing , Zhang Jing Song . Relationship between the Proportion of Tumor Infiltrating Lymphocytes in Tumor Mass and Postoperative Recurrence of Prostate Carcinoma[J]. Journal of Kunming Medical University, 2018, 39(03): 62-66.

PDF( 415 KB)

Relationship between the Proportion of Tumor Infiltrating Lymphocytes in Tumor Mass and Postoperative Recurrence of Prostate Carcinoma

Funds:

基金：云南省科技厅-昆明医科大学应用基础研究联合专项基金资助项目 (2017FE468);

Received Date: 2017-11-19

Abstract

Abstract

Objective To investigate the relationship between proportion of Tumor infiltrating lymphocytes (TILs) in the prostate tumor mass and postoperative recurrence of prostate carcinoma in order to offer the theoretic as well as experimental basis for the prevention of postoperative recurrence in the prostate carcinoma.Methods The proportion of CD3+, CD8+, CD3+CD4+, CD3+CD8+ TILs cells of 81 PCa specimens underwent Radical prostatectomy were analyzed. The proportion of CD3+CD8+TILs in patients with recurrence of PCa within3 years after surgery (group A), within 35 years (group B) and without recurrence after 5 years (group C) was compared. Results The proportion of CD3+CD8+TILs was significantly lower in group A than that of in group B and C (P<0.05), meanwhile, the proportion of CD3+CD8+TILs were significantly higher in group C than that in group A and B (P<0.05), while="" the="" proportion="" of="" in="" three="" groups="" had="" no="" significant="" difference="" p="">0.05). Conclusion The proportion of CD3+CD8+TILs presented in the PCa specimen mass is relative to the postoperative recurrence of prostate cancer, which might be a biomarker for the surveillance of postoperative recurrence of PCa.
- Prostate cancer,
- Recurrence,
- Tumor infiltrating lymphocytes

FullText(HTML)

References(18)

References

[1]孙颖浩:前列腺癌诊治进展[J].上海医学, 2011, (7) :487-488.
[2]	[2]GILBERT R, MARTIN R M, EVANS D M, et al.Incorporating known genetic variants does not improve the accuracy of PSA testing to identify high risk prostate cancer on biopsy[J].PLo S One, 2015, 10 (10) :e0136735.
[3]	[3]CHAMIE K, WILLIAMS S B, HERSHMAN D L, et al.Population-based assessment of determining predictors for quality of prostate cancer surveillance[J].Cancer, 2015, 121 (23) :4150-4157.
[4]刘峰, 陈冬, 贤少忠, 等.腹腔镜下前列腺癌根治术与开放性手术的治疗效果对比分析[J].癌症进展, 2016, (3) :232-235.
[5]	[5]ROSENBERG S A, SPIESS P, LAFRENIERE R.A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes[J].Science, 1986, 233 (4770) :1318-1321.
[6]	[6]ADAMS S, GRAY R J, DEMARIA S, et al.Prognostic value of tumor-infiltrating lymphocytes in triplenegative breast cancers from two phase III randomized adjuvant breast cancer trials:ECOG 2197 and ECOG1199[J].J Clin Oncol, 2014, 32 (27) :2959-2966.
[7]	[7]BALERMPAS P, MICHEL Y, WAGENBLAST J, et al.Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer[J].Br J Cancer, 2014, 110 (2) :501-509.
[8]	[8]AMATO R, STEPANKIW M, GONZALES P.A phase II trial of androgen deprivation therapy (ADT) plus chemotherapy as initial treatment for local failures or advanced prostate cancer[J].Cancer Chemother Pharmacol, 2013, 71 (6) :1629-1634.
[9]	[9]HELPAP B, RINGLI D, TONHAUSER J, et al.The significance of accurate determination of gleason score for therapeutic options and prognosis of prostate cancer[J].Pathol Oncol Res, 2016, 22 (2) :349-356.
[10]	[10]WILT T J, BRAWER M K, JONES K M, et al:Radical prostatectomy versus observation for localized prostate cancer[J].N Engl J Med, 2012, 367 (3) :203-213.
[11]	[11]WITZ I P.Yin-yang activities and vicious cycles in the tumor microenvironment[J].Cancer Res, 2008, 68 (1) :9-13.
[12]	[12]LI H, FAN X, HOUGHTON J.Tumor microenvironment:the role of the tumor stroma in cancer[J].J Cell Biochem, 2007, 101 (4) :805-815.
[13]	[13]FRIDMAN W H, PAGES F, SAUTES-FRIDMAN C, et al.The immune contexture in human tumours:impact on clinical outcome[J].Nat Rev Cancer, 2012, 12 (4) :298-306.
[14]	[14]SATO E, OLSON S H, AHN J, et al.Intraepithelial CD8+tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer[J].Proc Natl Acad Sci USA, 2005, 102 (51) :18538-18543.
[15]	[15]FU J, XU D, LIU Z, et al.Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients[J].Gastroenterology, 2007, 132 (7) :2328-2339.
[16]	[16]ZHANG Y L, LI J, MO H Y, et al.Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways[J].Mol Cancer, 2010, 9 (1) :4.
[17]	[17]WU H, CHEN P, LIAO R, et al.Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients[J].J Gastroenterol Hepatol, 2013, 28 (9) :1555-1564.
[18]	[18]CROCI D O, ZACARIAS FLUCK M F, RICO M J, et al.Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment[J].Cancer Immunol Immunother, 2007, 56 (11) :1687-1700.

Relative Articles(20)

Relative Articles

[1]	Peilin CUI, Yuxia SONG, Xuejuan WANG. Predictive Value of Serum and Tissue miR-205 for Postoperative Recurrence of Ovarian-type Endometriosis. Journal of Kunming Medical University, 2024, 45(10): 105-110. doi: 10.12259/j.issn.2095-610X.S20241016
[2]	Qian LI, Puqiong FENG, Qin YAO, Hanmei CHEN, Ting ZHAO, Hui WU. Risk Factors of Recurrence in Patients with Ischemic Stroke Treated with Aspirin Single Drug Antiplatelet Therapy. Journal of Kunming Medical University, 2024, 45(1): 78-82. doi: 10.12259/j.issn.2095-610X.S20240113
[3]	Wei WANG, Sheng LIU, Hongqing ZHOU, Mingsheng LIU, Pingbo XIE, Feng GUO, Guanyu CHEN. Clinical Efficacy of Immediate Radical Surgery for Locally Advanced Prostate Cancer. Journal of Kunming Medical University, 2024, 46(): 1-8.
[4]	Quanchang ZHANG, Qiaolian WU, Yu LIU, Xin ZHAO. The Impact of Laparoscopic and Open Total Mesocolon Resection on Platelet Activation，Incidence of Complications，and Tumor Recurrence in Colon Cancer Patients. Journal of Kunming Medical University, 2023, 44(9): 104-109. doi: 10.12259/j.issn.2095-610X.S20230919
[5]	Xiaofeng ZHU, Guangping ZHOU, Laicang WANG, Houjun ZHOU, Xin GENG, Hualin YU, Jinghui LI, Peng BAI. Clinical Effect of Reoperation for Recurrent Glioma. Journal of Kunming Medical University, 2022, 43(9): 77-83. doi: 10.12259/j.issn.2095-610X.S20220920
[6]	Xilan WU, Hong SHEN, Susheng SHI, Zhihui ZHANG, Lei GUO, Fang WANG. The Expression of PD-L1, BRAF^V600E, CD68 Protein and the Significance of Tumor Infiltrating Lymphocytes in the Diagnosis of Malignant Melanoma. Journal of Kunming Medical University, 2022, 43(9): 13-18. doi: 10.12259/j.issn.2095-610X.S20220923
[7]	Bin ZHAO, Yuanpeng DUAN, Guoying ZHANG, Chengwei BI, Libo YANG, Zhiyu SHI, Yong YANG, Jianpeng ZHANG, Ting GAO. CircRNA EZH2 Promotes Proliferation and Migration of Prostate Cancer Cells by Regulating miR-30c-5p. Journal of Kunming Medical University, 2022, 43(7): 25-32. doi: 10.12259/j.issn.2095-610X.S20220731
[8]	Ming-xiong ZHANG, Xiao-wen ZHANG. The Risk Factor Analysis for Recurrence in the Treatment of Choledochojejunostomy for Hepatolithiasis. Journal of Kunming Medical University, 2021, 42(9): 76-82. doi: 10.12259/j.issn.2095-610X.S20210937
[9]	Sun Jian Wei , Wang Jian Song , Liu Zi Chao , Zheng Li Min . . Journal of Kunming Medical University, 2020, 41(01): 18-25.
[10]	Li Hui , Ping Qin Rong , Shi Yun Qiang , Wang Chun Hui , Yang Yang , Hu Li Bing , Bi Xiao Fang , Li Jian , Zhong Yi Ming . . Journal of Kunming Medical University, 2020, 41(01): 52-56.
[11]	Zhao Bin , Li Rui Qian , Zhang Guo Ying , Lei Yong Hong , Wang Qi Lin , Liu Zhi Min . Overexpression of miR-4328 Inhibits the Proliferation, Migration and Epithelial Mesenchymal Transition of Prostate Cancer Cells. Journal of Kunming Medical University, 2017, 38(11): 29-33.
[12]	Li Hong . . Journal of Kunming Medical University,
[13]	Ma Yin Rui . . Journal of Kunming Medical University,
[14]	Shen Hong . . Journal of Kunming Medical University,
[15]	Zhang Jing Song . . Journal of Kunming Medical University,
[16]	Lei Jing . . Journal of Kunming Medical University,
[17]	Du Xiong . . Journal of Kunming Medical University,
[18]	Liu Peng Jie . . Journal of Kunming Medical University,
[19]	Sun Jian Wei . . Journal of Kunming Medical University,
[20]	Liu Xiao Dong . . Journal of Kunming Medical University,